Osisko Development Corp. (CVE:ODV – Get Free Report)’s share price traded up 0.7% during mid-day trading on Tuesday . The company traded as high as C$3.00 and last traded at C$2.91. 14,600 shares changed hands during trading, a decline of 60% from the average session volume of 36,813 shares. The stock had previously closed at C$2.89.
Analyst Ratings Changes
Several equities analysts have recently weighed in on ODV shares. Ventum Financial lowered their price objective on shares of Osisko Development from C$7.50 to C$4.50 in a research note on Thursday, August 29th. Eight Capital decreased their price target on shares of Osisko Development from C$11.00 to C$9.00 in a research report on Thursday, July 11th. Finally, Royal Bank of Canada cut their price objective on shares of Osisko Development from C$6.00 to C$5.00 and set an “outperform” rating for the company in a research report on Tuesday, September 10th.
Get Our Latest Analysis on ODV
Osisko Development Trading Up 0.7 %
Osisko Development (CVE:ODV – Get Free Report) last issued its quarterly earnings results on Monday, August 12th. The company reported C($0.34) earnings per share for the quarter. The business had revenue of C$2.63 million for the quarter. As a group, equities analysts forecast that Osisko Development Corp. will post 0.1150546 earnings per share for the current year.
About Osisko Development
Osisko Development Corp. acquires, explores, and develops mineral properties in Canada, Mexico, and the United States. It explores for gold; and precious and base metals. The company's flagship asset is the Cariboo Gold Project covering an area of approximately 155,000 hectares consisting of 415 mineral titles located in British Columbia, Canada.
See Also
- Five stocks we like better than Osisko Development
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Why Lennar Stock Could Be the Best Play in the Housing Market
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Roth IRA Calculator: Calculate Your Potential Returns
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Osisko Development Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Osisko Development and related companies with MarketBeat.com's FREE daily email newsletter.